Stockholders' Equity (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	May 10, 2018
Stockholders' Equity (Details) [Line Items]
Common stock description	At the Company’s annual meeting of stockholders held on May 3, 2017, the Company’s stockholders approved amendments to the Company’s Eighth Amended and Restated Certificate of Incorporation (as amended, the “Certificate of Incorporation”) to (i) effect a reverse stock split of the Company’s common stock; and (ii) decrease the Company’s authorized number of shares of common stock to three times the number of shares of the Company’s common stock outstanding immediately following the reverse stock split. On May 3, 2017, following the annual meeting, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to (a) implement the reverse stock split at a ratio of 1-for-10; and (b) to reduce the number of authorized shares of common stock from 40,000,000 to 8,200,000, consequently reducing the number of total authorized shares from 45,000,000 to 13,200,000. With the completion of the reverse stock split, the Company’s shares began trading above the required $1.00 per share closing bid price, as required by the Listing Qualifications Department of NASDAQ. The share information has been retroactively reflected for the effects of this reverse stock split for all periods presented
Preferred stock, shares authorized	1,000,000	1,000,000
Reserved shares of common stock for issuance	32,080
Common stock reserved for future grants	304,731
Maximum [Member]
Stockholders' Equity (Details) [Line Items]
Preferred stock, shares authorized	13,200,000		5,000,000
Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Preferred stock, shares authorized	9,200,000		1,000,000